Skip Nav Destination
Issues
1 November 2012
-
Cover Image
Cover Image
The cover image shows a multiphoton microscopic image of an azoxymethane-induced aberrant crypt focus (ACF) in the colon of a mouse (300 × magnification). The ACF is an early neoplastic lesion comprised of aberrant crypts lined by cells with low-grade dysplasia as defined by elongated and crowded nuclei within epithelial cells (green) and is surrounded by a thick band of connective tissue (red). Mucin is also observed within the aberrant crypts (blue). Multiphoton microscopy (MPM) uses endogenous signals from fresh tissue to generate images and is able to recapitulate tissue morphology at a level of detail comparable to standard hematoxylin and eosin staining. This image demonstrates the ability of MPM to visualize neoplastic lesions within the colon and provides the basis for potential “optical biopsies” for the early detection of neoplasia. See article by Makino et al. (beginning on page 1280) for more information. - PDF Icon PDF LinkTable of Contents
ISSN 1940-6207
EISSN 1940-6215
Issue Sections
Perspective
Review
Research Articles
Multiphoton Tomographic Imaging: A Potential Optical Biopsy Tool for Detecting Gastrointestinal Inflammation and Neoplasia
Tomoki Makino; Manu Jain; David C. Montrose; Amit Aggarwal; Joshua Sterling; Brian P. Bosworth; Jeffrey W. Milsom; Brian D. Robinson; Maria M. Shevchuk; Kathy Kawaguchi; Ning Zhang; Christopher M. Brown; David R. Rivera; Wendy O. Williams; Chris Xu; Andrew J. Dannenberg; Sushmita Mukherjee
Dietary Administration of δ- and γ-Tocopherol Inhibits Tumorigenesis in the Animal Model of Estrogen Receptor–Positive, but not HER-2 Breast Cancer
Amanda K. Smolarek; Jae Young So; Brenda Burgess; Ah-Ng Tony Kong; Kenneth Reuhl; Yong Lin; Weichung Joe Shih; Guangxun Li; Mao-Jung Lee; Yu-Kuo Chen; Chung S. Yang; Nanjoo Suh
Baseline Mammographic Breast Density and the Risk of Invasive Breast Cancer in Postmenopausal Women Participating in the NSABP Study of Tamoxifen and Raloxifene (STAR)
Reena S. Cecchini; Joseph P. Costantino; Jane A. Cauley; Walter M. Cronin; D. Lawrence Wickerham; Hanna Bandos; Joel L. Weissfeld; Norman Wolmark
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.